Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 9, 2014 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences

Takeshi Ohno1 Department of Respiratory Medicine and Allergology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan

Shota Wada1 Department of Respiratory Medicine and Allergology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan

Souichirou Hanada1 Department of Respiratory Medicine and Allergology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan

Hirochiyo Sawaguchi1 Department of Respiratory Medicine and Allergology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, Japan

Masato Muraki1 Department of Respiratory Medicine and Allergology, Nara Hospital, Kinki University Faculty of Medicine, Ikoma, JapanCorrespondence[email protected]

Yuji Tohda2 Department of Respiratory Medicine and Allergology, Kinki University School of Medicine, Osakasayama, Japan

Pages 107-114 | Published online: 21 Jan 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J20062739741216452599
PubMed Web of Science ®Google Scholar
MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med20063e44217132052
PubMed Web of Science ®Google Scholar
GershonASWarnerLCascagnettePVictorJCToTLifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population studyLancet201137899199621907862
PubMed Web of Science ®Google Scholar
MäkeläMJBackerVHedegaardMLarssonKAdherence to inhaled therapies, health outcomes and costs in patients with asthma and COPDRespir Med20131071481149023643487
PubMed Web of Science ®Google Scholar
BalintBWatzHAmosCOwenRHigginsMKramerBINSURE Study InvestigatorsOnset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasoneInt J Chron Obstruct Pulmon Dis2010531131820856830
PubMedGoogle Scholar
DahlRChungKFBuhlREfficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPDThorax20106547347920522841
PubMed Web of Science ®Google Scholar
BleeckerERSilerTOwenRKramerBBronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled dataInt J Chron Obstruct Pulmon Dis2011643143822003288
PubMed Web of Science ®Google Scholar
KornmannODahlRCentanniSOnce-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonEur Respir J20113727327920693243
PubMed Web of Science ®Google Scholar
GrossNJSkorodinMSRole of the parasympathetic system in airway obstruction due to emphysemaN Engl J Med19843114214256749189
PubMed Web of Science ®Google Scholar
SchockenDDRothGSReduced beta-adrenergic receptor concentrations in ageing manNature1977267856858197415
PubMed Web of Science ®Google Scholar
VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med20113641093110321428765
PubMed Web of Science ®Google Scholar
VogelmeierCRamos-BarbonDJackDIndacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropiumRespir Res20101113520920365
PubMed Web of Science ®Google Scholar
Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for diagnosis, management, and prevention of chronic obstructive lung disease [updated 2013] Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdfAccessed December 9, 2013
Google Scholar
VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax20096493994319703830
PubMed Web of Science ®Google Scholar
HanJDaiLZhongNIndacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trialsBMC Pulm Med2013132623617268
PubMed Web of Science ®Google Scholar
HatajiONaitoMItoKWatanabeFGabazzaECTaguchiOIndacaterol improves daily physical activity in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis201381523293514
PubMed Web of Science ®Google Scholar
MrozRMMinarowskiLChyczewskaEIndacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patientsAdv Exp Med Biol2013756232822836615
PubMed Web of Science ®Google Scholar
KornSKerwinEAtisSAmosCOwenRLassenCINSIST study groupIndacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week studyRespir Med201110571972621367594
PubMed Web of Science ®Google Scholar
FeldmanGJImproving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterolInt J Chron Obstruct Pulmon Dis20138899623431038
PubMed Web of Science ®Google Scholar
SegretiAFioriECalzettaLThe effect of indacaterol during an acute exacerbation of COPDPulm Pharmacol Ther201326663063423578980
PubMed Web of Science ®Google Scholar
DonohueJFFogartyCLötvallJOnce-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumAm J Respir Crit Care Med201018215516220463178
PubMed Web of Science ®Google Scholar
MahlerDABuhlRLawrenceDMcBryanDEfficacy and safety of indacaterol and tiotropium in COPD patients according to dyspnoea severityPulm Pharmacol Ther20132634835523434446
PubMed Web of Science ®Google Scholar
BuhlRDunnLJDisdierCBlinded 12-week comparison of once-daily indacaterol and tiotropium in COPDEur Respir J20113879780321622587
PubMed Web of Science ®Google Scholar
MahlerDAD’UrzoABatemanEDConcurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonThorax20126778178822544891
PubMed Web of Science ®Google Scholar
JiangFMLiangZAZhengQLWangRCLuoJLiCTSafety and efficacy of 12-week or longer indacaterol treatment in moderate-to-severe COPD patients: a systematic reviewLung201319113514623306410
PubMed Web of Science ®Google Scholar
LareauSCYawnBPImproving adherence with inhaler therapy in COPDInt J Chron Obstruct Pulmon Dis2010540140621191434
PubMedGoogle Scholar
RestrepoRDAlvarezMTWittnebelLDMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis2008337138418990964
PubMedGoogle Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date